Company · CIK 2029039

# Nasus Pharma Ltd

| CIK | [2029039](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002029039) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | L3 |
| Business address | Israel |
| Listed | NSRX (NYSE) |
| First annual or quarterly report | 2026-03-25 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-298693 | Shelf Effective | 2026-09-01 | 2026-09-18 | 3 |
| 333-293950 | First-time registration Effective | 2026-03-02 | 2026-08-20 | 4 |
| 333-288582 | IPO Final prospectus | 2025-07-09 | 2025-08-14 | 5 |

## Filings

 13

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-09-18 | [424B5](https://www.sec.gov/Archives/edgar/data/2029039/000149315226043370/0001493152-26-043370-index.htm) Shelf takedown | 333-298693 | 0001493152-26-043370 |
| 2026-09-11 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2029039/999999999526002954/9999999995-26-002954-index.htm) Declared effective | 333-298693 | 9999999995-26-002954 |
| 2026-09-01 | [F-3](https://www.sec.gov/Archives/edgar/data/2029039/000149315226041040/0001493152-26-041040-index.htm) Shelf registered | 333-298693 | 0001493152-26-041040 |
| 2026-08-20 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2029039/999999999526002715/9999999995-26-002715-index.htm) Declared effective | 333-293950 | 9999999995-26-002715 |
| 2026-03-31 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2029039/999999999526001019/9999999995-26-001019-index.htm) Declared effective | 333-293950 | 9999999995-26-001019 |
| 2026-03-13 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2029039/999999999526000817/9999999995-26-000817-index.htm) Declared effective | 333-293950 | 9999999995-26-000817 |
| 2026-03-02 | [F-1](https://www.sec.gov/Archives/edgar/data/2029039/000149315226008581/0001493152-26-008581-index.htm) Registration filed | 333-293950 | 0001493152-26-008581 |
| 2025-08-14 | [424B4](https://www.sec.gov/Archives/edgar/data/2029039/000164117225023826/0001641172-25-023826-index.htm) Final prospectus | 333-288582 | 0001641172-25-023826 |
| 2025-08-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2029039/999999999525002578/9999999995-25-002578-index.htm) Declared effective | 333-288582 | 9999999995-25-002578 |
| 2025-08-07 | [F-1/A](https://www.sec.gov/Archives/edgar/data/2029039/000149315225011714/0001493152-25-011714-index.htm) Amendment | 333-288582 | 0001493152-25-011714 |
| 2025-07-28 | [F-1/A](https://www.sec.gov/Archives/edgar/data/2029039/000149315225011444/0001493152-25-011444-index.htm) Amendment | 333-288582 | 0001493152-25-011444 |
| 2025-07-09 | [F-1](https://www.sec.gov/Archives/edgar/data/2029039/000164117225018388/0001641172-25-018388-index.htm) Registration filed | 333-288582 | 0001641172-25-018388 |
| 2024-08-30 | [DRS](https://www.sec.gov/Archives/edgar/data/2029039/000149315224034512/0001493152-24-034512-index.htm) Draft made public | 377-07416 | 0001493152-24-034512 |

[All filings of this company](https://equitycapital.markets/filings?cik=2029039) · [CSV](https://equitycapital.markets/filings.csv?cik=2029039)

---
Source page: https://equitycapital.markets/company/2029039 · Data: U.S. SEC EDGAR · CC BY 4.0